CAR-T therapy Follow-Up study shows no new safety surprises
NCT ID NCT04488354
First seen Apr 22, 2026 · Last updated Jun 05, 2026 · Updated 7 times
Summary
This study followed 16 people who had already received a special immune cell treatment (CLBR001 CAR-T) for various types of B-cell blood cancers like lymphoma and leukemia. The goal was to check for any new or long-term side effects that might appear months or years after treatment. Researchers also looked at how well the cancer was controlled over time. This was a safety-focused follow-up, not a test of a new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA ( FL) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope National Medical Center
Duarte, California, 91010, United States
-
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, 55455, United States
-
Sarah Cannon Research Institute - Tennessee Oncology
Nashville, Tennessee, 37203, United States
-
Sarah Cannon Research Institute - Texas Transplant Institute
San Antonio, Texas, 78229, United States
-
University of California at San Diego
San Diego, California, 92093, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
Wake Forest Baptist Health
Winston-Salem, North Carolina, 27157, United States
-
Weill Cornell Medical College - New York Presbyterian Hospital
New York, New York, 10065, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.